info@news-matic.com

details

FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION

Novel bispecific antibody with a dual mechanism of action targeting anemia of inflammation in chronic kidney disease, autoimmune disease, and cancer Experienced leadership and advisory team with deep expertise in antibody engineering, red blood cell biology, and nephrology Seed financing...

Cookie Consent + Tracking